Lois B Travis

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi request reprint The epidemiology of second primary cancers
    Lois B Travis
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Executive Plaza South, Suite 7086, Bethesda, MD 20892, USA
    Cancer Epidemiol Biomarkers Prev 15:2020-6. 2006
  2. ncbi request reprint Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma
    Lois B Travis
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
    J Natl Cancer Inst 97:1428-37. 2005
  3. ncbi request reprint Acute myeloid leukemia following Hodgkin lymphoma: a population-based study of 35,511 patients
    Sara J Schonfeld
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892 7238, USA
    J Natl Cancer Inst 98:215-8. 2006
  4. ncbi request reprint Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk
    Anil K Chaturvedi
    Viral Epidemiology Branch, Division of Cancer Epidemiology and Genetics, 6120 Executive Blvd, EPS 7072, Rockville, MD 20852, USA
    J Natl Cancer Inst 99:1634-43. 2007
  5. pmc Risk of leukemia among survivors of testicular cancer: a population-based study of 42,722 patients
    Regan Howard
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
    Ann Epidemiol 18:416-21. 2008
  6. pmc Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors
    Deirdre A Hill
    Division of Cancer Epidemiology and Genetics and Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA
    Blood 106:3358-65. 2005
  7. ncbi request reprint Risk of second non-hematological malignancies among 376,825 breast cancer survivors
    Linda Morris Brown
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, 6120 Executive Blvd, MSC 7244, Bethesda, MD 20892 7244, USA
    Breast Cancer Res Treat 106:439-51. 2007
  8. ncbi request reprint Second cancers among 40,576 testicular cancer patients: focus on long-term survivors
    Lois B Travis
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Natl Cancer Inst 97:1354-65. 2005
  9. ncbi request reprint Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease
    Lois B Travis
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
    JAMA 290:465-75. 2003
  10. pmc Radiation dose and subsequent risk for stomach cancer in long-term survivors of cervical cancer
    Ruth A Kleinerman
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Rockville, Maryland, USA
    Int J Radiat Oncol Biol Phys 86:922-9. 2013

Collaborators

Detail Information

Publications44

  1. ncbi request reprint The epidemiology of second primary cancers
    Lois B Travis
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Executive Plaza South, Suite 7086, Bethesda, MD 20892, USA
    Cancer Epidemiol Biomarkers Prev 15:2020-6. 2006
    ....
  2. ncbi request reprint Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma
    Lois B Travis
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
    J Natl Cancer Inst 97:1428-37. 2005
    ..We estimated this future risk, taking into account age and calendar year of HL diagnosis, HL treatment information, population breast cancer incidence rates, and competing causes of death...
  3. ncbi request reprint Acute myeloid leukemia following Hodgkin lymphoma: a population-based study of 35,511 patients
    Sara J Schonfeld
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892 7238, USA
    J Natl Cancer Inst 98:215-8. 2006
    ..The EAR of AML declined statistically significantly after 1984 (7.0 to 4.2 and 16.4 to 9.9 in the < 35 and > or = 35 age groups, respectively), which may be associated with modifications in chemotherapy...
  4. ncbi request reprint Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk
    Anil K Chaturvedi
    Viral Epidemiology Branch, Division of Cancer Epidemiology and Genetics, 6120 Executive Blvd, EPS 7072, Rockville, MD 20852, USA
    J Natl Cancer Inst 99:1634-43. 2007
    ....
  5. pmc Risk of leukemia among survivors of testicular cancer: a population-based study of 42,722 patients
    Regan Howard
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
    Ann Epidemiol 18:416-21. 2008
    ..The aim of this study is to quantify excess absolute risk (EAR) and excess relative risk (ERR) of secondary leukemia among a large population-based group of testicular cancer survivors...
  6. pmc Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors
    Deirdre A Hill
    Division of Cancer Epidemiology and Genetics and Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA
    Blood 106:3358-65. 2005
    ..The additional increased relative risk of breast cancer after RT for HL is unlikely to be larger among women with a family history of breast or ovarian cancer than among other women...
  7. ncbi request reprint Risk of second non-hematological malignancies among 376,825 breast cancer survivors
    Linda Morris Brown
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, 6120 Executive Blvd, MSC 7244, Bethesda, MD 20892 7244, USA
    Breast Cancer Res Treat 106:439-51. 2007
    ....
  8. ncbi request reprint Second cancers among 40,576 testicular cancer patients: focus on long-term survivors
    Lois B Travis
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Natl Cancer Inst 97:1354-65. 2005
    ..Although second primary cancers are a leading cause of death among men with testicular cancer, few studies have quantified risks among long-term survivors...
  9. ncbi request reprint Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease
    Lois B Travis
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
    JAMA 290:465-75. 2003
    ..Quantitative associations between radiotherapy dose delivered to the breast and administered chemotherapy have not been reported to date in large series, nor has the influence of ovarian exposures on subsequent risk...
  10. pmc Radiation dose and subsequent risk for stomach cancer in long-term survivors of cervical cancer
    Ruth A Kleinerman
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Rockville, Maryland, USA
    Int J Radiat Oncol Biol Phys 86:922-9. 2013
    ..To assess the dose-response relationship for stomach cancer after radiation therapy for cervical cancer...
  11. ncbi request reprint Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations
    Lois B Travis
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
    J Natl Cancer Inst 98:15-25. 2006
    ..These research areas warrant high priority to promote NCI's goal of eliminating pain and suffering related to cancer...
  12. pmc Stomach cancer risk after treatment for hodgkin lymphoma
    Lindsay M Morton
    Lindsay M Morton, Graça M Dores, Rochelle E Curtis, Ethel S Gilbert, Ruth A Kleinerman, and Joseph F Fraumeni Jr, National Cancer Institute, Bethesda, MD Graça M Dores, Department of Veterans Affairs Medical Center, Oklahoma City, OK Charles F Lynch, University of Iowa, Iowa City, IA Marilyn Stovall, Susan A Smith, and Rita E Weathers, University of Texas MD Anderson Cancer Center, Houston, TX Per Hall and Magnus Kaijser, Karolinska Institute, Stockholm, Sweden David C Hodgson and Eric J Holowaty, University of Toronto, Toronto, Ontario, Canada Hans H Storm, Danish Cancer Society Michael Andersson, Copenhagen University Hospital, Copenhagen, Denmark Tom Børge Johannesen and Frøydis Langmark, Cancer Registry of Norway Sophie D Fossa, Oslo University Hospital and University of Oslo, Oslo, Norway Michael Hauptmann, Alexandra W Van den Belt Dusebout, Berthe M Aleman, and Flora E van Leeuwen, Netherlands Cancer Institute, Amsterdam, National Cancer Institute of Milan
    J Clin Oncol 31:3369-77. 2013
    ..Treatment-related stomach cancer is an important cause of morbidity and mortality among the growing number of Hodgkin lymphoma (HL) survivors, but risks associated with specific HL treatments are unclear...
  13. ncbi request reprint Leukemia following breast cancer: an international population-based study of 376,825 women
    Regan A Howard
    Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Executive Plaza South, Suite 7091, Bethesda, MD 20892, USA
    Breast Cancer Res Treat 105:359-68. 2007
    ....
  14. pmc Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation
    Ola Landgren
    Division of Cancer Epidemiology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
    Blood 113:4992-5001. 2009
    ..Our findings identify subgroups of patients who underwent allogeneic HCT at elevated risk of PTLDs for whom prospective monitoring of Epstein-Barr virus activation and early treatment intervention may be particularly beneficial...
  15. ncbi request reprint Suicide after breast cancer: an international population-based study of 723,810 women
    Catherine Schairer
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 6120 Executive Blvd, Rm 8020, MSC 7244, Rockville, MD 20852 7244, USA
    J Natl Cancer Inst 98:1416-9. 2006
    ..08) and remained elevated among women diagnosed between 1990 and 2001 (SMR = 1.36, 95% CI = 1.18 to 1.57). The cumulative probability of suicide was 0.20% 30 years after breast cancer diagnosis...
  16. pmc Second cancers after squamous cell carcinoma and adenocarcinoma of the cervix
    Anil K Chaturvedi
    Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 6120 Executive Blvd, EPS 7072, Rockville, MD 20852, USA
    J Clin Oncol 27:967-73. 2009
    ..We assessed whether these cofactor differences translate into differences in second cancer risk...
  17. ncbi request reprint Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study
    Michie Hisada
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 6120 Executive Blvd, EPS 8008, Bethesda, MD 20892 7201, USA
    J Natl Cancer Inst 99:215-22. 2007
    ..The available evidence is conflicting, with most risk estimates based on sparse numbers. To our knowledge, no study has evaluated cause-specific mortality in patients with hairy cell leukemia...
  18. ncbi request reprint Comparative mortality for 621 second cancers in 29356 testicular cancer survivors and 12420 matched first cancers
    Catherine Schairer
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
    J Natl Cancer Inst 99:1248-56. 2007
    ..However, no data on outcomes of testicular cancer survivors with second cancers compared to patients with comparable first cancers exist...
  19. ncbi request reprint Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years
    Graca M Dores
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Executive Plaza South, Suite 7039, Bethesda, MD 20892, USA
    J Clin Oncol 20:3484-94. 2002
    ....
  20. pmc Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research
    Joanne W Elena
    Clinical and Translational Epidemiology Branch, DCCPS 6130 Executive Blvd, rm 5136 Bethesda, MD 20892, USA
    J Natl Cancer Inst 105:85-94. 2013
    ....
  21. ncbi request reprint Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study
    Catherine Metayer
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA
    Blood 101:2015-23. 2003
    ..Transplantation-related factors may also modulate this risk; however, the apparent contribution of high-dose TBI requires confirmation...
  22. pmc Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study
    Rochelle E Curtis
    Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Executive Plaza South, Suite 7042, 6120 Executive Blvd, Bethesda, MD 20892, USA
    Blood 105:3802-11. 2005
    ..Our results also suggest that clinical screening for SCC is appropriate among patients exposed to persistent chronic GVHD, prolonged immunosuppressive therapy, or both...
  23. ncbi request reprint Site-specific cancer incidence and mortality after cerebral angiography with radioactive thorotrast
    Lois B Travis
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, Maryland 20892, USA
    Radiat Res 160:691-706. 2003
    ..Nonetheless, the substantial risks associated with liver cancer and leukemia indicate that unique and prolonged exposure to alpha-particle-emitting Thorotrast increased carcinogenic risks...
  24. ncbi request reprint Risk of second malignant neoplasms among lymphoma patients with a family history of cancer
    Ola Landgren
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD 20892, USA
    Int J Cancer 120:1099-102. 2007
    ..99, 95% CI: 0.73-5.39). Our observations suggest that genetic factors, as measured by positive family history of cancer, may be influential risk-factors for selected second tumors following lymphoproliferative disorders...
  25. ncbi request reprint Therapy-associated solid tumors
    Lois B Travis
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA
    Acta Oncol 41:323-33. 2002
    ..Thus, the benefit derived from many cancer therapies far outweighs any risk of developing a second cancer...
  26. ncbi request reprint Merkel cell carcinoma and multiple primary cancers
    Regan A Howard
    Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Bethesda, MD 20892 7238, USA
    Cancer Epidemiol Biomarkers Prev 15:1545-9. 2006
    ..Heightened awareness of the associations of lymphohematopoietic malignancies with MCC may facilitate early clinical recognition...
  27. ncbi request reprint Second malignant neoplasms and cardiovascular disease following radiotherapy
    Lois B Travis
    Rubin Center for Cancer Survivorship and Department of Radiation Oncology, James P Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY Department of Radiation Oncology, Brigham and Women s Hospital, Harvard Medical School, Boston, MA and the Dana Farber Cancer Institute, Boston, MA Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK Department of Oncology, St Jude Children s Research Hospital, Memphis, TN and the University of Tennessee Health Science Center, Memphis, TN Department of Radiation Oncology, University of Pennsylvania School of Medicine, Philadelphia, PA Nuclear Engineering and Engineering Physics Program, Rensselaer Polytechnic Institute, Troy, NY Department of Radiation Oncology, University of California at Davis, Davis, CA Department of Radiology, Emory University, Atlanta, GA Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY Division ofCancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD National Council on Radiation Protection and Measurements, Bethesda, MD, and the Department of Medicine, Vanderbilt University, Nashville, TN
    Health Phys 106:229-46. 2014
    ....
  28. doi request reprint Cancer survivorship: facing forward
    Lois B Travis
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Department of Health and Human Services, National Institutes of Health, Bethesda, MD, USA
    Hematol Oncol Clin North Am 22:365-71, ix. 2008
    ..In this article, the authors briefly review the history of the efforts that served to coalesce efforts to champion survivorship research, identify future challenges, and provide a perspective on future recommendations...
  29. ncbi request reprint Amyotrophic lateral sclerosis mortality in 1.9 million US cancer survivors
    D Michal Freedman
    Division of Epidemiology and Genetics, National Cancer Institute, NIH DHHS, Rm 7036 Executive Plaza South, 6120 Executive Boulevard, Bethesda, MD 20892 7238, USA
    Neuroepidemiology 25:176-80. 2005
    ..Large cancer registries offer the opportunity to explore and generate hypotheses about the pathogenesis of cancer and other diseases, including neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS)...
  30. ncbi request reprint Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease
    Lois B Travis
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA
    J Natl Cancer Inst 94:182-92. 2002
    ..We quantified the risk of treatment-associated lung cancer, taking into account tobacco use...
  31. ncbi request reprint Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: An analysis of 26,758 cases
    Jorge R Toro
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892 7231, USA
    Int J Cancer 119:2922-30. 2006
    ..Incidence patterns of STS varied markedly by histologic type, supporting the notion that these tumors may be etiologically distinct...
  32. doi request reprint Cancer Survivorship. Preface
    Lois B Travis
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Department of Health and Human ServicesNational Institutes of Health, Bethesda, MD, USA
    Hematol Oncol Clin North Am 22:xi-xii. 2008
  33. ncbi request reprint Suicide after childhood cancer
    Regan A Howard
    J Clin Oncol 25:731; author reply 733-4. 2007
  34. ncbi request reprint Risk of contralateral testicular cancer: a population-based study of 29,515 U.S. men
    Sophie D Fossa
    Department of Clinical Cancer Research, The Norwegian Radium Hospital, University of Oslo, Norway
    J Natl Cancer Inst 97:1056-66. 2005
    ..We evaluated the risk of contralateral testicular cancer and survival in a large population-based cohort of men diagnosed with testicular cancer before age 55 years...
  35. ncbi request reprint Cancer incidence among Swedish patients exposed to radioactive thorotrast: a forty-year follow-up survey
    Ullakarin Nyberg
    Department of Medical Epidemiology, Karolinska Institutet, Stockholm, Sweden
    Radiat Res 157:419-25. 2002
    ..In addition, there may be a relationship between radiation exposure and the development of other solid tumors...
  36. ncbi request reprint Second primary cancers after thymoma
    Lois B Travis
    Int J Cancer 107:868-70. 2003
  37. ncbi request reprint The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma
    Linda Morris Brown
    Cancer 107:2741-2; author reply 2742. 2006
  38. doi request reprint Second primary cancers: an overview
    Andrea K Ng
    Department of Radiation Oncology, Dana Farber Cancer Institute, Brigham and Women s Hospital, Harvard Medical School, 75 Francis Street, ASB1 L2, Boston, MA 02115, USA
    Hematol Oncol Clin North Am 22:271-89, vii. 2008
    ..The focus of this article is treatment-associated malignancies in survivors of selected adult cancers...
  39. ncbi request reprint An intron splice acceptor polymorphism in hMSH2 and risk of leukemia after treatment with chemotherapeutic alkylating agents
    Lisa J Worrillow
    Leukaemia Research Fund Epidemiology and Genetics Unit, Academic Unit of Epidemiology, School of Medicine, University of Leeds, Leeds LS2 9JT, United Kingdom
    Clin Cancer Res 9:3012-20. 2003
    ..We also determined the extent of microsatellite instability (MSI) in therapy-related acute myeloid leukemia (t-AML) as a marker of dysfunctional DNA mismatch repair...
  40. ncbi request reprint Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease
    Flora E van Leeuwen
    Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands
    J Natl Cancer Inst 95:971-80. 2003
    ..Female survivors of Hodgkin's disease (HD) have a strongly elevated risk of breast cancer, but factors responsible for the increased risk are not well known...
  41. ncbi request reprint Noncancer causes of death in survivors of testicular cancer
    Sophie D Fossa
    Department of Clinical Cancer Research, Rikshospitalet Radiumhospitalet Trust, Oslo, Norway
    J Natl Cancer Inst 99:533-44. 2007
    ..We conducted a population-based study to quantify the long-term risks of mortality from noncancer causes among men with testicular cancer...
  42. ncbi request reprint Mechanisms of therapy-related carcinogenesis
    James M Allan
    Epidemiology and Genetics Unit, Department of Biology, University of York, Heslington, York, YO10 5YW, UK
    Nat Rev Cancer 5:943-55. 2005
    ..Unsurprisingly, some of these mechanisms seem to operate in the development of sporadic cancers...
  43. ncbi request reprint Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma
    David C Hodgson
    Princess Margaret Hospital, University Health Network, and the Department of Radiation Oncology, University of Toronto, Canada
    J Clin Oncol 25:1489-97. 2007
    ..However, no investigation has used multivariate modeling to estimate the relative risk (RR), excess absolute risk (EAR), and cumulative incidence for specific attained ages and ages at HL diagnosis...
  44. ncbi request reprint p53 mutations in leukemia and myelodysplastic syndrome after ovarian cancer
    Debra G B Leonard
    Department of Pathology, University of Pennsylvania School of Medicine, Philadelphia 19104, USA
    Clin Cancer Res 8:973-85. 2002
    ..The purpose of this study was to examine p53 mutations in leukemias after ovarian cancer, for which treatment with platinum analogues was widely used...